virus
small
infecti
agent
infect
nearli
organ
caus
sever
infecti
diseas
human
use
chemic
therapi
eg
ribavirin
vaccin
prove
effect
protect
viral
infect
infect
like
human
immunodefici
viru
hiv
cohen
et
al
hepat
b
viru
hbv
dienstag
influenza
virus
lambert
fauci
remain
great
challeng
progress
genom
sequenc
project
complet
genom
virus
sequenc
time
write
review
http
wwwncbinlmnihgovgenomesgenomesgroupcgi
lead
new
era
viral
genom
proteom
burley
et
al
pandey
mann
dongr
et
al
collin
et
al
tyer
mann
previou
studi
mainli
base
genom
proteom
approach
made
signific
progress
establish
foundat
investig
interact
chakravarti
et
al
wilson
richardson
wu
et
al
infectom
term
first
introduc
huang
et
al
novel
mean
global
comprehens
understand
interact
microbi
pathogen
host
rather
microbi
pathogen
three
type
infectom
approach
develop
antimicrobi
drug
discoveri
ecolog
infectom
immunoinfectom
chemic
infectom
huang
et
al
among
acceler
develop
infectom
approach
greatli
contribut
drug
discoveri
effort
approach
includ
mass
spectrometri
ms
proteom
protein
profil
abpp
microarray
analysi
yeast
yth
assay
small
interf
rna
sirna
screen
micro
rna
mirna
profil
use
studi
infectom
relat
viral
infect
lead
detail
mechan
interact
includ
hiv
brass
et
al
et
al
naji
et
al
hepat
c
viru
hcv
supekova
et
al
peng
et
al
influenza
viru
et
al
dengu
viru
denv
khadka
et
al
recent
progress
antivir
drug
research
base
infectom
approach
greatli
revolution
exist
strategi
new
antivir
compound
target
host
protein
enzym
preclin
research
eg
mccormack
et
al
bisindolylmaleimid
ludwig
et
al
nuclear
receptor
play
combinatori
role
inflamm
immun
glass
ogawa
novel
drug
target
repres
potenti
strategi
antivir
therapi
target
infectom
cellular
protein
molecul
may
lead
reduc
host
drug
resist
human
gene
encod
target
cellular
protein
less
like
mutat
respons
therapi
tan
et
al
infectom
approach
use
studi
complex
interact
facilit
screen
novel
antivir
drug
target
review
focu
infectom
approach
studi
interact
potenti
antivir
drug
discoveri
past
decad
mani
public
involv
viral
infect
focus
genom
proteom
approach
viral
perspect
gene
acquisit
delet
point
mutat
three
major
event
lead
evolut
microbi
pathogen
commens
point
mutat
frequent
lead
promot
viral
replic
drug
resist
surviv
abil
virus
enhanc
due
viral
point
mutat
indic
point
mutat
may
play
critic
role
viru
spread
exampl
spite
presenc
antibodi
e
antigen
serum
patient
infect
hbv
still
high
titer
hbv
dna
akahan
et
al
sequenc
precor
region
hbv
identifi
point
mutat
nucleotid
present
clone
hbv
propag
sera
seven
patient
anoth
mutat
nucleotid
clone
two
patient
respons
dysfunct
secret
e
antigen
point
mutat
limit
hbv
gener
viral
phenomenon
identifi
varieti
virus
includ
hiv
emiliani
et
al
hcv
heilek
peterson
denv
hanley
et
al
influenza
viru
melikyan
et
al
herp
simplex
viru
hsv
hwang
et
al
use
genom
proteom
approach
signific
progress
drug
discoveri
base
viral
encod
protein
occur
gel
electrophoresi
liquid
technolog
result
discoveri
mani
protein
may
repres
potenti
drug
target
includ
viral
enzym
like
revers
transcriptas
rt
integras
proteas
involv
viru
bind
revers
transcript
integr
bud
instanc
use
proteas
inhibitor
like
saquinavir
ritonavir
indinavir
nelfinavir
improv
treatment
patient
deek
et
al
eron
howev
mani
patient
treat
proteas
inhibitor
develop
toler
condra
et
al
yerli
et
al
requir
enhanc
knowledg
landscap
viral
infect
furthermor
host
factor
play
essenti
role
viral
infect
could
also
serv
novel
antivir
drug
proteom
analysi
primari
sequenc
interact
posttransl
modif
etc
use
studi
cellular
state
determin
molecular
aspect
cellular
function
owe
complex
protein
low
abund
proteom
rabilloud
monteoliva
albar
righetti
et
al
indispens
tool
viral
system
biolog
fig
aebersold
mann
ion
trap
fenn
et
al
pitteri
et
al
makarov
et
al
second
et
al
shaner
et
al
tof
marklein
et
al
seng
et
al
prodhom
et
al
quadrupl
abzalimov
kaltashov
ramanathan
et
al
fourier
ion
cyclotron
analyz
leon
et
al
allwood
et
al
thee
four
basic
type
mass
analyz
use
proteom
investig
multipl
option
avail
collect
data
analysi
includ
affin
tag
haqqani
et
al
stabl
isotop
label
amino
acid
cell
cultur
asara
et
al
osserman
et
al
viral
host
genom
sequenc
proteom
employ
research
interact
electrophoresi
proteom
power
tool
infectom
research
laser
success
use
combin
infectom
analys
chlamydia
pneumonia
elementari
bodi
cell
c
trachomati
reticul
bodi
hela
cell
huang
et
al
hcv
nonstructur
protein
nonstructur
protein
play
critic
role
rna
bind
huang
et
al
replic
tarao
et
al
et
al
exact
role
remain
unknown
particularli
interact
choi
et
al
identifi
heat
shock
protein
protein
specif
use
ms
analysi
approach
moreov
region
aa
found
interact
amino
acid
domain
heat
shock
endoplasm
reticulum
suggest
import
role
heat
shock
kou
et
al
examin
possibl
host
factor
inhibit
translat
cultur
cell
interact
libbu
et
al
stasko
et
al
glutathion
interact
protein
found
congruent
human
translat
eukaryot
elong
factor
furthermor
central
domain
residu
interact
caus
inhibit
hcv
intern
ribosom
entri
translat
activ
infecti
diseas
proteom
research
also
made
signific
progress
tat
protein
necessari
viral
replic
may
play
critic
part
diseas
rashe
et
al
interestingli
infect
cell
protect
apoptosi
surviv
longer
bear
virion
although
precis
mechan
unclear
appear
like
tat
protein
respons
protect
coira
et
al
use
proteom
number
cytoskelet
protein
eg
actin
gelsolin
cofilin
annexin
ii
rac
nucleotid
dissoci
inhibitor
complex
found
downregul
tat
protein
reduc
express
protein
limit
cytoskelet
chang
induc
apoptosi
thu
maintain
virion
approach
use
screen
potenti
inhibitor
tat
protein
novel
therapeut
agent
use
nuclear
magnet
reson
msm
studi
jayasuriya
et
al
discov
durhamycin
inhibitor
tat
transactiv
proteom
explor
common
virus
includ
dengu
pattanakitsakul
et
al
higa
et
al
influenza
william
et
al
schwahn
et
al
sever
acut
respiratori
coronaviru
zeng
et
al
jiang
et
al
human
respiratori
syncyti
viru
brasier
et
al
munday
et
al
abpp
technolog
monitor
protein
enzym
nativ
environ
thu
elimin
need
recombin
express
purif
develop
specif
assay
chemic
probe
target
mani
member
given
enzym
class
protein
famili
use
evalu
activ
candid
compound
directli
complex
proteom
identifi
protein
function
valid
biolog
role
prerequisit
lead
discoveri
fig
discoveri
revers
enzym
inhibitor
simplifi
chemic
proteom
approach
order
character
specif
cellular
function
cystein
proteas
requir
surviv
malaria
parasit
plasmodium
falciparum
chemic
proteom
screen
use
character
predomin
proteas
falcipain
identifi
activ
proteas
invas
merozoit
stage
specif
inhibitor
falcipain
identifi
screen
abl
block
parasit
invas
host
erythrocyt
suggest
falcipain
play
specif
role
host
cell
invas
inhibitor
enzym
repres
potenti
new
agent
antimalari
therapeut
greenbaum
et
al
microarray
analysi
array
solid
substrat
use
screen
method
assay
larg
amount
biolog
materi
et
al
first
use
studi
small
mustard
plant
arabidopsi
thaliana
schena
et
al
use
studi
yeast
shalon
et
al
human
schena
et
al
mous
lockhart
et
al
compar
tradit
approach
princip
advantag
microarray
larg
number
target
analyz
parallel
measur
low
sampl
consumpt
fig
similar
recombin
dna
jackson
et
al
polymeras
chain
reaction
pcr
mulli
faloona
microarray
semin
technolog
broad
applic
stear
et
al
includ
genom
derisi
et
al
hugh
et
al
sudarsanam
et
al
proteom
geiss
et
al
macbeath
schreiber
eickhoff
et
al
two
commonli
use
microarray
dna
protein
templin
et
al
bulyk
et
al
arenkov
et
al
macbeath
schreiber
zhu
et
al
bulyk
et
al
differ
type
interact
ge
studi
dna
microarray
shift
direct
antivir
screen
program
ration
strategi
schmid
chan
et
al
fritz
raczniak
mcdevitt
et
al
parkinson
cheng
et
al
sinc
first
report
investig
alter
host
gene
express
geiss
et
al
microarray
use
hiv
studi
izmailova
et
al
khodakov
et
al
investig
macrophag
respons
infect
african
swine
fever
viru
zhang
et
al
genom
comparison
tuberculosi
vaccin
strain
variant
bacillu
mycobacterium
tuberculosi
helicobact
pylori
staphylococcu
aureu
conduct
use
dna
microarray
analysi
provid
new
inform
evolut
human
pathogen
suggest
ration
approach
design
improv
diagnost
antimicrobi
agent
howev
bridg
gap
genom
therapeut
challeng
research
process
falb
jindal
zander
et
al
protein
microarray
also
provid
platform
target
identif
cluster
secret
protein
identifi
cell
factor
caf
zhang
et
al
secret
cluster
differenti
certain
immunolog
stabl
patient
suppress
replic
specif
antibodi
recognit
amino
acid
sequenc
use
confirm
ident
caf
protein
microarray
use
malaria
parasit
surfac
protein
develop
studi
parasit
diseas
et
al
characterist
two
isol
novel
pandem
viru
compar
directli
carbohydr
microarray
analysi
child
et
al
yth
assay
field
song
technolog
studi
interact
field
yth
protein
interest
fuse
domain
transfect
yeast
host
cell
report
gene
control
domain
fusion
protein
use
bait
target
screen
librari
cdna
clone
fuse
activ
domain
function
transcript
factor
reconstitut
upon
physic
interact
bait
prey
protein
activ
report
gene
fig
yth
wide
use
studi
interact
includ
escherichia
coli
bacteriophag
bartel
et
al
hiv
rossi
et
al
hcv
matsumoto
et
al
mamiya
worman
kittlesen
et
al
khadka
et
al
use
yth
assay
studi
network
interact
denv
human
protein
valid
subset
interact
sirna
coloc
experi
result
first
analysi
interact
identifi
protein
requir
denv
replic
link
virus
show
protein
involv
denv
infect
also
link
virus
particularli
hcv
khadka
et
al
studi
provid
new
light
interact
well
new
potenti
drug
target
host
protein
mous
hepat
viru
mhv
use
model
studi
human
virus
studi
use
yth
intravir
protein
interact
protein
interact
identifi
never
report
lee
et
al
studi
may
reveal
potenti
cellular
protein
util
denv
may
serv
new
target
therapeut
intervent
studi
stomat
viru
et
al
sesbania
mosaic
viru
chowdhuri
savithri
flaviviru
le
breton
et
al
influenza
viru
sharma
et
al
tafforeau
et
al
human
cytomegaloviru
et
al
human
viru
htlv
type
retrovirus
simoni
et
al
also
provid
novel
insight
interact
variant
yth
includ
membran
yth
system
etch
viru
system
mammalian
interact
trap
suter
et
al
compar
yth
new
technolog
like
revers
yth
yeast
system
provid
integr
data
understand
interact
provid
new
strategi
antivir
drug
discoveri
instanc
inhibitor
dimer
use
disrupt
interact
induc
viral
infect
may
prevent
viral
infect
replic
proteas
rt
invertas
hiv
dna
polymeras
hsv
play
critic
role
hiv
hsv
infect
drug
target
hiv
hsv
therapi
archakov
et
al
rna
interfer
rnai
mechan
within
live
cell
modul
gene
activ
fire
et
al
wide
use
studi
gene
function
associ
molecular
mechan
hannon
mello
cont
sinc
initi
studi
rnai
screen
caenorhabd
elegan
fraser
et
al
et
al
rnai
screen
routin
use
studi
interact
enabl
loss
function
screen
host
cell
fig
echeverri
perrimon
boutro
ahring
mohr
et
al
ou
et
al
rnai
screen
identifi
human
host
cell
gene
influenc
influenza
viru
replic
karla
et
al
host
protein
cell
cycl
regul
identifi
key
influenza
viru
replic
small
molecul
inhibitor
cell
divis
kinas
reduc
influenza
viru
replic
anoth
studi
identifi
cellular
cofactor
requir
influenza
viru
replic
factor
necessari
viral
entri
confirm
et
al
host
cellular
factor
influenc
infect
identifi
factor
particip
earli
stage
hiv
infect
brass
et
al
et
al
rnai
screen
identifi
host
factor
involv
viru
progress
includ
hcv
li
et
al
tai
et
al
west
nile
viru
krishnan
et
al
denv
session
et
al
drosophila
c
viru
cherri
et
al
mirna
lee
et
al
play
import
role
control
stress
signal
mendel
olson
metabol
rottier
naar
tumorigenesi
chen
interact
jopl
et
al
lecelli
et
al
mirna
profil
technolog
includ
quantit
revers
transcript
method
method
quantif
pritchard
et
al
greatli
enhanc
knowledg
regard
role
mirna
interact
fig
mirna
profil
technolog
combin
messeng
rna
mrna
profil
provid
new
insight
interact
investig
mirna
mrna
involv
hcv
infect
identifi
differenti
express
mirna
differenti
express
mrna
express
level
chang
hcv
infect
liu
et
al
steuerwald
et
al
alter
express
level
mirna
mrna
involv
metabol
cell
growth
apoptosi
cytokinechemokin
pathway
progress
chronic
hepat
anoth
studi
reveal
mirna
downregul
cell
mirna
upregul
braconi
et
al
identifi
mirna
put
target
may
use
basi
therapi
suggest
combin
mirna
mrna
profil
may
repres
novel
approach
understand
hcv
infect
design
new
strategi
antisens
inhibitor
mirna
function
biovail
vivo
eg
antagomir
repres
good
start
point
develop
mirna
inhibitori
drug
krutzfeldt
et
al
gottwein
et
al
howev
antisens
inhibitor
target
cellular
mirna
predict
side
effect
inhibitor
could
also
disrupt
cellular
function
mirna
moreov
like
treatment
antivir
drug
viru
may
becom
resist
eg
mutat
viral
mirna
viral
bind
site
cellular
mirna
gottwein
cullen
case
therapeut
would
need
use
combin
antivir
drug
use
technolog
tabl
new
insight
interact
occur
suggest
host
cellular
signal
pathway
may
hijack
promot
viru
infect
make
interact
complex
previous
thought
receptor
cell
membran
adaptor
molecul
cytoplasm
nuclear
transcript
factor
dai
et
al
repres
three
categori
host
signal
molecul
play
import
role
interact
delarco
todaro
albritton
et
al
doria
et
al
choe
et
al
yoneyama
et
al
wari
et
al
hemmi
et
al
perri
et
al
fig
phosphoinositid
famili
lipid
kinas
involv
intracellular
signal
cascad
play
essenti
role
apoptosi
autophagi
tumorigenesi
wong
et
al
bartholomeusz
influenza
viru
interrupt
pathway
creat
suitabl
environ
replic
past
decad
nearli
classic
signal
pathway
report
particip
viral
infect
transform
growth
signal
initi
cascad
bind
specif
cell
surfac
receptor
intrins
serinethreonin
kinas
activ
ten
dijk
hill
modul
hcv
infect
lee
et
al
rowan
et
al
tumorigenesi
hepat
b
viru
x
protein
liver
hepat
c
viru
core
protein
play
essenti
role
shift
signal
tumor
suppress
tumorigenesi
transit
battaglia
et
al
murata
et
al
nuclear
factor
kappa
b
famili
transcript
factor
play
key
role
orchestr
innat
acquir
host
immun
respons
pathogen
infect
rahman
mcfadden
bovin
foami
viru
activ
pathway
via
action
transactiv
enhanc
viral
transcript
wang
et
al
viral
protein
involv
activ
includ
tax
viral
protein
inhibit
pathway
includ
nuclear
antigen
open
read
frame
torqu
teno
viru
kaposi
herp
viru
kshv
encod
mirna
control
viral
replic
activ
pathway
demonstr
import
role
kshv
mirna
regul
viral
latenc
lytic
replic
via
manipul
host
surviv
pathway
lei
et
al
suggest
viral
protein
also
mirna
could
particip
regul
host
signal
pathway
interact
indic
cellular
process
play
import
role
viral
infect
autophagi
divid
three
categori
microautophagi
autophagi
macroautophagi
cecconi
levin
link
innat
adapt
immun
versu
viral
infect
lee
iwasaki
orvedahl
levin
autophagi
activ
et
al
alavian
et
al
inhibit
zhou
spector
et
al
viral
infect
turn
autophagi
also
promot
lee
et
al
inhibit
orvedahl
et
al
viral
infect
therefor
unravel
role
autophagi
viral
infect
import
target
autophagi
may
provid
new
strategi
antivir
therapi
apoptosi
glucos
metabol
also
involv
viral
infect
noch
et
al
demonstr
role
jc
viru
john
cunningham
viru
regul
glucos
metabol
brain
tumor
cell
downregul
oxythiamin
also
modul
express
glycolyt
enzym
hexokinas
pentos
phosphat
enzym
transaldolas
viru
inhibit
induct
lymphoma
homolog
contain
protein
noxa
ionomycin
inhibit
apoptosi
b
cell
yee
et
al
addit
hcv
protein
compon
cytoplasm
hcv
replic
complex
hugl
et
al
report
induc
apoptosi
via
mitochondrila
pathway
zhao
et
al
find
suggest
cellular
process
host
cell
could
alter
viral
infect
could
contribut
develop
new
strategi
target
process
combat
viral
infect
fig
mani
novel
technolog
platform
becom
avail
omic
approach
wide
use
drug
discoveri
studi
base
genom
proteom
approach
establish
foundat
investig
interact
creat
opportun
develop
novel
antimicrobi
agent
six
infectom
technolog
commonli
use
drug
discoveri
describ
review
proteom
abpp
microarray
analysi
yth
assay
sirna
screen
mirna
profil
togeth
potenti
elucid
integr
dynam
interact
microbi
pathogen
host
develop
infecti
diseas
chemic
infectom
advantag
chemistri
infectom
emerg
method
valid
drug
target
revolution
approach
infecti
diseas
infectom
view
provid
global
detect
integr
dissect
microbi
host
infectom
critic
understand
process
microbi
pathogenesi
develop
better
diagnost
therapeut
approach
infecti
diseas
ii
power
tool
investig
microbi
human
genom
address
present
crisi
antibiot
resist
iii
new
method
util
pharmacom
drug
deliveri
system
optim
drug
therapi
iv
opportun
exploit
probiot
ecolog
approach
infecti
diseas
tool
prevent
treatment
microbi
infect
eventu
enter
era
holist
solut
health
problem
effici
individu
